The monoclonal antibody is the first non-factor, once-weekly treatment approved in the United States for hemophilia B.

Testing rates for mismatch repair and microsatellite instability among patients with CRC increased from 2012 to 2021, but ...

Only 13.4% immunocompromised adult US veterans younger than 50 years received the recombinant zoster vaccine by mid-2023, ...

Delays in cancer registration probably led to a major underestimation of the effectiveness of screening colonoscopy in ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was linked to an overall 3% increase in self-reported ...

Evidence suggested there is little risk in administering the live rotavirus vaccine to the babies of mothers on biologics ...

New phase 3 results should reopen discussion about the off-label use of COMT inhibitors in early Parkinson's disease, experts ...

High caffeine intake can stimulate diuresis, but without causing damaging effects on hydration when taking moderate doses of ...

Visualizing microvascular changes could aid diagnosis in arthritis, cancer, and peripheral vascular disease, among other ...

A new study highlights the potential of using smartphone data collected in real-world situations for the early detection of ...

A psychosocial intervention that aimed to improve parenting skills and symptoms of depression in Pakistani fathers is an ...

An experimental immunotherapy candidate targets toxic species of alpha-synuclein and was well tolerated in an ongoing, ...